Corrigendum to “Novel and orally bioavailable inducible nitric oxide synthase inhibitors: synthesis and evaluation of optically active 4,5-dialkyl-2-iminoselenazolidine derivatives”: [Bioorg. Med. Chem. Lett. 15 (2005) 1361]